- Home
- NATR vs CDTX Comparison
NATR vs CDTX Comparison
Compare NATR & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- CDTX
- Stock Information
- Founded
- NATR 1972
- CDTX 2012
- Country
- NATR United States
- CDTX United States
- Employees
- NATR N/A
- CDTX N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NATR Health Care
- CDTX Health Care
- Exchange
- NATR Nasdaq
- CDTX Nasdaq
- Market Cap
- NATR 267.5M
- CDTX 229.0M
- IPO Year
- NATR N/A
- CDTX 2015
- Fundamental
- Price
- NATR $14.98
- CDTX $17.85
- Analyst Decision
- NATR Strong Buy
- CDTX Strong Buy
- Analyst Count
- NATR 2
- CDTX 7
- Target Price
- NATR $19.50
- CDTX $32.20
- AVG Volume (30 Days)
- NATR 27.2K
- CDTX 131.1K
- Earning Date
- NATR 03-11-2025
- CDTX 11-07-2024
- Dividend Yield
- NATR N/A
- CDTX N/A
- EPS Growth
- NATR 114.95
- CDTX N/A
- EPS
- NATR 0.88
- CDTX N/A
- Revenue
- NATR $445,095,000.00
- CDTX $44,653,000.00
- Revenue This Year
- NATR $2.07
- CDTX N/A
- Revenue Next Year
- NATR $2.62
- CDTX N/A
- P/E Ratio
- NATR $16.94
- CDTX N/A
- Revenue Growth
- NATR 1.36
- CDTX 44.48
- 52 Week Low
- NATR $10.81
- CDTX $10.00
- 52 Week High
- NATR $21.72
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- NATR 53.23
- CDTX 35.14
- Support Level
- NATR $14.34
- CDTX $17.59
- Resistance Level
- NATR $15.30
- CDTX $22.65
- Average True Range (ATR)
- NATR 0.40
- CDTX 2.03
- MACD
- NATR 0.10
- CDTX -0.75
- Stochastic Oscillator
- NATR 78.81
- CDTX 2.60
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.